<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000285638"><TermName>RK-0202</TermName><TermDefinition><DefinitionText>A substance that is being studied in the prevention of oral mucositis in patients receiving radiation therapy or chemotherapy for head and neck cancer.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><SpanishTermName>RK-0202</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para la prevención de la mucositis oral en pacientes que reciben radioterapia o quimioterapia para el cáncer de cabeza y cuello.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2003-02-21</DateFirstPublished></GlossaryTerm>
